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A Major Reduction in Hospital-Onset
Staphylococcus aureus Bacteremia in Australia—
12 Years of Progress: An Observational Study
Brett G. Mitchell,1,2 Peter J. Collignon,3 Rebecca McCann,4 Irene J. Wilkinson,5 and Anne Wells6
1Faculty of Nursing and Health, Avondale College for Higher Education, Wahroonga, New South Wales; 2School of Nursing, Midwifery and Paramedicine,
Australian Catholic University, Dickson; 3Canberra Hospital and Medical School, Australian National University, Australian Capital Territory; 4Healthcare
Associated Infection Unit, Department of Health, Perth, Western Australia; 5Infection Control Service, Department of Health, Adelaide, South Australia;
and 6Tasmanian Infection Prevention and Control Unit, Department of Health and Human Services, Hobart, Tasmania, Australia
Background. Staphylococcus aureus bacteremia (SAB) is a serious cause of morbidity and mortality. This lon-
gitudinal study describes significant reductions in hospital-onset SAB (HO-SAB) in Australian hospitals over the
past 12 years.
Methods. An observational cohort study design was used. Prospective surveillance of HO-SAB in 132 hospitals
in Australia was undertaken. Aggregated data from all patients who acquired HO-SAB was collected (defined as 1 or
more blood cultures positive for S. aureus taken from a patient who had been admitted to hospital for >48 hours).
The primary outcome was the incidence of HO-SAB, including both methicillin-resistant (MRSA) and methicillin-
susceptible (MSSA) S. aureus strains.
Results. A total of 2733 HO-SAB cases were identified over the study period, giving an aggregate incidence of
0.90 per 10 000 patient-days (PDs) (95% confidence interval [CI], .86–.93). There was a 63% decrease in the annual
incidence, from 1.72 per 10 000 PDs in 2002 (95% CI, 1.50–1.97) to 0.64 per 10 000 PDs (95% CI, .53–.76) in 2013.
The mean reduction per year was 9.4% (95% CI, −8.1% to −10.7%). Significant reductions in both HO-MRSA (from
0.77 to 0.18 per 10 000 PDs) and HO-MSSA (from 1.71 to 0.64 per 10 000 PDs) bacteremia were observed.
Conclusions. There was a major and significant reduction in incidence of HO-SAB caused by both MRSA and
MSSA in Australian hospitals since 2002. This reduction coincided with a range of infection prevention and control
activities implemented during this time. It suggests that national and local efforts to reduce the burden of healthcare-
associated infections have been very successful.
Keywords. bacteremia; bloodstream infection; healthcare-associated infections; infection control; Staphylococcus
aureus.
In the past decade, efforts to decrease healthcare-
associated infections (HAIs) have increased worldwide.
More than a decade ago, the landmark report “To Err Is
Human: Building a Safer Health System” had a major
impact on focusing the attention of policy makers, the
public, and healthcare workers (HCWs) on improving
patient safety in healthcare facilities [1, 2]. In response,
HCWs, hospitals, and health authorities across the
world have increased efforts to keep people safe from
potential harm associated with receiving healthcare
[3, 4]. One infection of particular interest has been
Staphylococcus aureus bacteremia (SAB). Worldwide,
SAB is a serious cause of morbidity and mortality,
with associated mortality rates of 20%–50% [5–7] and
a significant associated economic burden [8].
HAI surveillance programs have been established in
numerous countries to monitor and control the occur-
rence of HAIs. The prevention of infection requires a
multifaceted approach [9], often making it difficult to
determine the relative effect of each intervention. In
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the case of SAB, interventions to reduce its incidence include
hand hygiene initiatives and improvements in the management
of intravascular catheters [10–13]. Despite global concerns
about serious HAIs such as SAB and the need to monitor the
effect of interventions, international comparisons are limited.
There are few longitudinal studies describing the incidence of
SAB across a wide region [14]. The purpose of this longitudinal
study is to describe significant reductions in hospital-onset SAB
(HO-SAB) in Australian hospitals over the past 12 years.
METHODS
The study presents an analysis of prospective surveillance of
laboratory-diagnosed HO-SAB cases according to agreed defi-
nitions [15].The primary outcome was HO-SAB, which was de-
fined as 1 or more blood cultures positive for S. aureus, taken
from a patient who had been admitted to hospital for >48
hours. The term HO-SAB is defined as any case of SAB occur-
ring >48 hours after admission. Only the first isolate per patient
was counted, unless at least 14 days had passed without a pos-
itive blood culture, after which an additional episode was re-
corded. Surveillance data were collected and combined from
132 hospitals in 4 Australian states and territories, representing
24% of all Australian hospitals that reported having 1 or more
patient-days in 2011–2012. Of the 132 hospitals, 110 are publicly
funded; the reminder are privately funded. In Australia, approx-
imately 68% of all hospital beds are publicly funded [16]. Data
from all admissions to inpatient wards or units within acute pub-
lic hospitals, including psychiatric, rehabilitation, and aged care
admissions were included. For the period 1 January 2002–30
June 2013, HO-SAB surveillance and hospital bed-day data
were provided by the Australian Capital Territory (ACT), South
Australia (SA), Tasmania (TAS), and Western Australia (WA)
HAI surveillance units. All jurisdictions involved in this study
have a system where laboratory data can be directly extracted
and used for validation of reported cases. Data from the states
with larger populations (New SouthWales, Victoria, andQueens-
land) were not available for the time period used for this study.
All contributing hospitals used the HO-SAB definition as de-
scribed earlier and provided bed-day denominator data to the
HAI surveillance units. There were minor variations in the de-
nominator used to calculate rates. ACT and WA used occupied
bed-days (OBDs) for the entire study period, whereas SA used
OBDs from 2002 to June 2006, and subsequently used patient-
days [16]. Similarly, TAS used OBDs from 2005 until June 2008,
when patient days were subsequently used. The changes in de-
nominators during the study period have negligible impact as
the yearly variance between the 2 measures (“occupied” com-
pared to “patient” days) is estimated to be <1% [17]. For conve-
nience, we use the term patient-days (PDs) for the remainder of
the paper.
Statistical Analysis
Statistical analysis was conducted using IBM Statistics version
20.0. The incidence of HO-SAB per 10 000 PDs was calculated
as [HO-SAB cases / number of PDs × 10 000]; 95% confidence
intervals (CIs) were calculated for Poisson distributed counts.
Monthly, quarterly, and yearly incidence rates were obtained
for HO-SAB. Monthly incidence of HO-SAB over the entire
study period was tested using time-series analysis (regression
analysis), to allow for autocorrelation between monthly mea-
surements. Adjustment for seasonality was not undertaken.
To determine whether there was an issue of “dilution” of rates
from the later inclusion of PDs from smaller hospitals with a
much lower-risk patient population and very few episodes, fur-
ther analysis was undertaken. First, when new hospitals contrib-
uted data, comparisons of the mean HO-SAB rate before and
after the addition of new hospitals were undertaken using
analysis of variance. Second, monthly aggregate incidence of
HO-SAB from the original 15 contributing hospitals and
from larger, more complex peer group hospitals (principal re-
ferral hospitals as defined by the Australian Institute of Health
and Welfare) [18] was analyzed separately over the entire study
period using time-series analysis.
Ethical Statement
This study was approved by the human research ethics commit-
tee at Avondale College of Higher Education (H0013060).
RESULTS
The number of hospitals contributing data to the state surveil-
lance systems increased progressively from 15 in 2002 to 132
hospitals by 2011; this number was sustained until 2013. Of
these 132 hospitals, 81 were from SA, 46 from WA, 4 from
TAS, and 1 from ACT. A total of 2733 HO-SAB cases were iden-
tified over the study period, giving an aggregate incidence of
0.90 per 10 000 PDs (95% CI, .86–.93). There was a 63% de-
crease in the annual incidence, from 1.72 per 10 000 PDs in
2002 (95% CI, 1.50–1.97) to 0.64 per 10 000 PDs (95% CI,
.53–.76) in 2013. Further descriptive HO-SAB data by year
are presented in Table 1. Using time-series analysis (regression),
there was a mean reduction in the incidence of HO-SAB over
the entire study period of 9.4% per year (95% CI, −8.1% to
−10.7%; Figure 1).
Over the study period, the annual incidence of methicillin-
resistant S. aureus (MRSA) HO-SAB significantly reduced by
76% from 0.77 to 0.18 per 10 000 PDs (P < .001). The propor-
tion of HO-SAB that was caused by MRSA reduced from 44.7%
to 28.0%. Cases of HO-SAB caused by both MRSA and
methicillin-susceptible S. aureus (MSSA) significantly reduced
during the study period (P < .001) (Table 1 and Figure 2). Ag-
gregated data at the jurisdictional level also indicated a
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reduction in both MSSA and MRSA HO-SAB, consistent with
trends reported in Table 1 and Figure 1. These data are not spe-
cifically reported, as to do so would potentially identify individ-
ual hospitals.
During the study period, the number of hospitals contribut-
ing data increased from 15 to 132. When new hospitals contrib-
uted data, a significant decrease in the mean incidence of
HO-SAB only occurred when the number of contributing hos-
pitals increased from 16 to 19 in June 2005 (P = .02). There was
no further significant change to the mean incidence of HO-SAB
when additional hospitals contributed data.
To test the possibility that dilution of rates was occurring by
the addition of lower-risk hospitals’ data, analysis of data from
the original 15 contributing hospitals was undertaken for the
entire study period. In these 15 hospitals, there was a significant
reduction in the incidence of HO-SAB of 6.5% (95% CI, −4.9%
to −8.1%) per year, compared with 9.4% for the entire cohort of
hospitals. When analysis was performed on data from the prin-
cipal referral hospitals only [18], there was an annual mean
Table 1. Yearly Incidence of Hospital-Onset Staphylococcus aureus Bacteremia
Year Hospitals No. of PDs
Rate per 10 000 PDs
MSSA (95% CI) (No.) MRSA (95% CI) (No.) SAB (95% CI) (No.)
2002 15 1 208 009 0.95 (.79–1.14) (115) 0.77 (.62–.94) (93) 1.72 (1.50–1.97) (208)
2003 15 1 231 463 0.74 (.59–.91) (91) 0.60 (.47–.75) (74) 1.34 (1.14–1.56) (165)
2004 15 1 230 235 0.78 (.63–.95) (96) 0.46 (.34–.59) (56) 1.24 (1.05–1.45) (152)
2005 19 1 407 243 0.91 (.76–1.08) (128) 0.47 (.36–.60) (66) 1.38 (1.19–1.59) (194)
2006 19 1 620 486 0.79 (.66–.94) (128) 0.33 (.25–.43) (54) 1.12 (.97–1.30) (182)
2007 22 2 081 367 0.65 (.55–.77) (136) 0.29 (.22–.38) (61) 0.95 (.82–1.09) (197)
2008 65 3 566 709 0.71 (.63–.81) (254) 0.24 (.19–.29) (85) 0.95 (.85–1.06) (339)
2009 68 3 686 420 0.57 (.50–.65) (210) 0.21 (.17–.26) (78) 0.78 (.69–.88) (288)
2010 74 3 922 593 0.62 (.54–.70) (242) 0.18 (.14–.23) (71) 0.80 (.71–.89) (313)
2011 132 4 119 269 0.52 (.45–.60) (215) 0.23 (.18–.28) (93) 0.75 (.67–.84) (308)
2012 132 4 297 326 0.44 (.38–.50) (187) 0.16 (.12–.20) (68) 0.59 (.52–.67) (255)
2013a 132 2 072 993 0.46 (.37–.56) (95) 0.18 (.13–.25) (37) 0.64 (.53–.76) (132)
Total . . . 30 444 113 0.62 (.60–.65) (1897) 0.28 (.26–.29) (836) 0.90 (.86–.93) (2733)
Abbreviations: CI, confidence interval; MRSA, methicillin-resistant Staphylococcus aureus; MSSA, methicillin-susceptible Staphylococcus aureus; PD, patient-days;
SAB, Staphylococcus aureus bacteremia.
a Till 30 June 2013.
Figure 1. Quarterly incidence of hospital-onset Staphylococcus aureus
bacteremia—all hospitals, 2002 to 30 June 2013.
Figure 2. Quarterly incidence of hospital-onset methicillin-resistant
Staphylococcus aureus (MRSA) and methicillin-susceptible Staphylococ-
cus aureus (MSSA) bacteremia—all hospitals, 2002 to 30 June 2013.
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reduction in the incidence of HO-SAB of 11.2% (95% CI, −9.2%
to −13.2%). Therefore, it is unlikely that there was a significant
“dilution” effect caused by progressive inclusion of many small-
er hospitals to account for the observed results.
DISCUSSION
Our study reports a major, sustained, and significant reduction
in HO-SAB in a large number of Australian hospitals since
2002. Although other studies have also documented a reduction
in national incidence of HO-SAB [11, 19–23] they have mostly
focused on MRSA. None have reported such a large reduction
in both MSSA and MRSA HO bacteremia. Additionally, we re-
port longitudinal data, a key strength of our study.
Comparisons of the incidence of HO-SAB between countries
are difficult, given the variety of definitions for cases and de-
nominator data. In England, “Trust Apportioned” cases (occur-
ring after the third day of admission) of MRSA bacteremia have
been collected since 2008. This has a close similarity to the HO-
SAB definition used in our study. Their data suggest that a sig-
nificant reduction in incidence of MRSA bacteremia occurred
between 2008–2009 and 2012–2013, from an incidence of
0.43–0.12 cases per 10 000 bed-days (P < .01) [21]. This latter
figure in England is lower than that reported in our study
for 2013 (0.18 per 10 000 PDs). It is not possible to determine
whether a reduction in MSSA bacteremia also occurred
in England during the same period, as these data are not
available.
In a Scottish study, the prevalence of HO-SAB in an inpatient
population reported a 41% decrease between 2006 and 2010,
from 0.73 to 0.50 cases per 1000 acute OBDs [19].The incidence
of HO-MRSA bacteremia fell from 0.16 to 0.03 per 1000 acute
OBDs; however, unlike our study, the rates of HO-MSSA bac-
teremia remained unchanged. Their reported incidence of HO-
MRSA bacteremia is higher than the incidence in the last year of
our study (0.03 per 1000 acute OBDs vs 0.18 per 10 000 PDs),
assuming the calculation of bed-days is similar. The authors
suggested that the introduction of a universal MRSA admission
screening program was associated with significant reductions in
rates of MRSA bacteremia but made no discernible impact on
burdens from MSSA bacteremia and that declines occurred al-
most exclusively in MRSA-related disease [19]. There is no na-
tional mandate regarding MRSA or MSSA patient screening in
Australia. Consistent with other studies, the Scottish study
found that upward pressure on MSSA rates was not observed,
and that MRSA appears to add to, rather than displace,
MSSA infection [20].
There are no national data from the United States on the in-
cidence of HO-SAB; however, some studies provide insight into
trends. A study undertaken by Kallen and colleagues examined
invasive healthcare-associated MRSA infections in 9 metro-
politan areas [24]. In patients with an invasive HO-MRSA infec-
tion, the proportion of these caused by HO-MRSA bloodstream
infections decreased slightly from 87% to 84% between 2005
and 2008 (P = .06). A significant reduction in MRSA bacteremia
related to a device was also identified in Veteran Affairs hospi-
tals, after the introduction of MRSA prevention and control
bundle [23].
In the largest study of SAB to date, the incidence of SAB was
compared in 5 countries, incorporating nearly 20 000 episodes
[25].During the 9 years studied, several regions reported decreases
in HO-MSSA, but only 2 regions observed a significant decrease in
both HO-MSSA and HO-MRSA bacteremia (Copenhagen City
and Sherbrooke). In a recent study from Victoria in Australia,
data from 119 public and 4 private hospitals were analyzed
for a 3-year period (2010–2012) [26]. Healthcare-associated
SAB (ie, any case associated with receiving healthcare) infection
rates decreased from 1.4 to 0.7 per 10 000 OBDs (P < .001),
whereas healthcare-associated MRSA bacteremia decreased
from 0.4 to 0.1 per 10 000 OBDs (P < .001).
There are several potential explanations for the reduction in
HO-SAB described in our study. Australian states and territo-
ries have had a long history of implementing statewide infection
prevention and control initiatives. At a national level, the work
undertaken by the Australian Commission on Safety and Qual-
ity in Health Care (an independent statutory authority) in the
area of HAI prevention is notable [27].The Commission has led
several major HAI prevention initiatives that were additional to
those from state and local hospital initiatives. These initiatives
included the development of national surveillance programs for
HAIs, national evidence-based guidelines, training and support
for improved clinician capacity in infection prevention and con-
trol, development of a national hand hygiene initiative, and new
accreditation standards. Hospitals who contributed data to this
study were involved in these national initiatives, in addition to
local and jurisdictional HAI prevention initiatives. The reduc-
tion in SAB observed in this study is unique, given the reduction
in both MSSA and MRSA HO-SAB. We believe a major factor
was that national, jurisdictional, and local interventions did not
just focus on MRSA, but on all cases of healthcare-associated
SAB and an overall effort to reduce all HAIs [10, 12, 26–28].
Regardless of how the data in our study are analyzed, a sig-
nificant downward trend in the incidence of HO-SAB, includ-
ing MRSA and MSSA, is seen (Figure 3). To determine whether
the observed reduction in HO-SAB was simply offset by in-
creased healthcare delivery in the community and a subsequent
increase in non-inpatient healthcare-associated SAB, we exam-
ined 2 further pieces of data. First, we explored hospital activity
data and found there was only a 0.7% reduction in the average
number of hospital beds per 1000 population in Australia be-
tween 2007–2008 and 2011–2012 [29]. We also identified a
2.7% increase in overnight admissions in Australian hospitals
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over the same period [29]. Second, we examined non-inpatient
healthcare-associated SAB data for the 4 last years of our study
period in all jurisdictions. We found no evidence of an increase
in non-inpatient SAB during this time. Consequently, we are
confident that the decrease in HO-SAB observed in our study
was not offset by increases in non-inpatient SAB or changes
in the at risk population.
Our study is unique because we identified a significant de-
crease in both MRSA and MSSA HO-SAB over the course of
the study and are unaware of any nation reporting similar find-
ings in a longitudinal manner. Of the limited Australian popu-
lation-based studies available, data suggest that the overall
incidence of SAB (including HO and community-onset cases)
has not significantly increased or decreased in 2 regions within
Australia [25, 30]. Put simply, in Australia, reductions in
HO-SAB have not been driven by an overall reduction in the
incidence of SAB or reductions in either HO-MRSA or
HO-MSSA bacteremia individually, a point of distinction
from other notable studies [5, 11, 19].
A strength of this study is the application of a consistently
applied internationally recognized definition for HO-SAB,
and that data were captured for an extended period (12
years). However, a limitation of using this definition is that
not all cases of healthcare-associated SAB will be captured.
For example, cases of SAB occurring within 48 hours of hospi-
talization but associated with prior healthcare interventions
such as intravascular devices or surgery will not be included
[31]. Previous studies suggest that using a time frame of
48 hours postadmission will fail to identify approximately
30% of cases [26, 30]. It was not possible to obtain longitudinal
data using a more comprehensive healthcare-associated SAB
definition, as this approach did not commence in all states in
Australia until 2010. Further limitations of our study included
our inability to collect data on comorbidities, strain typing, and
Figure 3. Yearly incidence of hospital-onset Staphylococcus aureus bacteremia (HO-SAB), 2002 to 30 June 2013. Abbreviations: MRSA, methicillin-
resistant Staphylococcus aureus; MSSA, methicillin-susceptible Staphylococcus aureus; SAB, Staphylococcus aureus bacteremia.
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treatment data, which may have been helpful to explain ob-
served differences in incidence over long time periods.
All jurisdictions involved in this study have had a history of
making data publicly available on SAB, and the data presented
in our study are consistent with and significantly builds on pre-
viously published work [12, 25, 30]. We report an incidence of
HO-SAB in 2002 of 1.73 per 10 000 PDs. If this rate remained
constant during the entire study period, 5274 cases of SAB
would have potentially occurred in the contributing jurisdic-
tions. This suggests that there were about 2500 fewer cases of
HO-SAB across the study period from the participating hospi-
tals. As a result, assuming a mortality of 21%, ≥500 lives were
saved over the study period, as a result of the reduction in HO-
SAB incidence [7].
We commend those responsible for infection prevention and
control initiatives at a local, jurisdictional, and national level.
The Australian experience showing reductions in both MSSA
and MRSA HO-SAB highlights the need to tackle HAIs in a
multifaceted manner, with a strong national focus, supported
by local interventions. Policy makers should not focus preven-
tion strategies on one organism or infection, and researchers
should, where possible, consider the value of examining multi-
ple HAI outcomes to evaluate infection prevention initiatives.
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